"10.1371_journal.pone.0153231","plos one","2016-04-07T00:00:00Z","Koshiro Sonomoto; Kunihiro Yamaoka; Hiroaki Kaneko; Kaoru Yamagata; Kei Sakata; Xiangmei Zhang; Masahiro Kondo; Yukichi Zenke; Ken Sabanai; Shingo Nakayamada; Akinori Sakai; Yoshiya Tanaka","The First department of internal medicine, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan; Integrative technology research institute, Teijin Limited, Hino, Tokyo, Japan; Department of orthopedics, school of medicine, University of occupational and environmental health, Kitakyushu, Fukuoka, Japan; Rheumatology, National hospital organization Beppu medical center, Beppu, Oita, Japan; Internal medicine, division of rheumatology, Keio university, Shinjuku-ku, Tokyo, Japan; Research unit B, research division, Mitsubishi Tanabe pharma corporation, Yokohama, Kanagawa, Japan","Conceived and designed the experiments: K. Sonomoto K. Yamaoka HK K. Yamagata XZ MK SN AS YT. Performed the experiments: K. Sonomoto K. Yamagata K. Sakata XZ MK YZ K. Sabanai. Analyzed the data: K. Sonomoto K. Yamagata K. Sakata SN. Contributed reagents/materials/analysis tools: K. Sonomoto HK YZ K. Sabanai. Wrote the paper: K. Sonomoto K. Yamaoka K. Yamagata HK SN AS YT.","The authors of this manuscript have read the journals policy and have the following competing interests: YT has received consulting fees, speaking fees, and/or honoraria from Abbvie, Daiichi-Sankyo, Chugai, Takeda, Mitsubishi-Tanabe, Bristol-Myers, Astellas, Eisai, Janssen, Pfizer, Asahi-kasei, Eli Lilly, GlaxoSmithKline, UCB, Teijin, MSD, and Santen. YT has also received research grants from Mitsubishi-Tanabe, Takeda, Chugai, Astellas, Eisai, Taisho-Toyama, Kyowa-Kirin, Abbvie, and Bristol-Myers. KYamaoka has received consultant fees and speaking fees from Pfizer, Chugai, Mitsubishi-Tanabe, Takeda, GlaxoSmithKline, Nippon Shinyaku, Eli Lilly, Janssen, Eisai, Astellas, Acterlion. HK is employee of Teijin Limited. K. Sakata and MK are employees of Mitsubishi-Tanabe. This does not alter the authors adherence to PLOS ONE policies on sharing data and materials. AS has received consulting fees, speaking fees, and/or honoraria from Astellas, Chugai, Daiichi-Sankyo, and Taisho-Toyama. The other authors declare no conflicts of interest.","2016","04","Koshiro Sonomoto","KS",12,TRUE,1,1,1,1,TRUE,TRUE,TRUE,5,"6;8;10;11;12",TRUE
